Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Nov 01, 2006 (Vol. 26, No. 19)

Graham Matthews' Home Pages

  • Very pleasing visually
  • Needs more content
I stumbled onto Graham Matthews’ pages through a subset of them devoted to microscopy. There I discovered his interest in and talent for nature photography, and that led me to explore the rest of his pages. They bear the mark of a person who has many interests—gardening, radio, the environment, and others. The microscopy section appears to be the main interest, as judged by the number of entries and their frequency of updates. Using a vintage 1954 microscope, the author provides some stunning images of protozoans and other microbes. Not content to simply take images through the eyepiece, Graham dabbles with numerous technologies for imaging and comes up a winner for his efforts. Though there’s not much here besides images, there are a lot of them to appreciate.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »